Cidara Therapeutics, Inc. (CDTX) has 20 known insider and institutional holders on record. The largest holder is Mundipharma AG with 4,781,408 shares. Other notable holders include BIOTECH TARGET N V and Stein Jeffrey.
Over the last 12 months, insiders have made 13 transactions in CDTX stock — 12 buys (valued at $2.38M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
CDTX Insider Ownership
Top Holder
Mundipharma AG
4,781,408 shares
Buys (12 mo)
12
$2.38M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Mundipharma Ag |
10 Percent Owner |
4,781,408 |
2019-09-13 |
|
| 2 |
Biotech Target N V |
10 Percent Owner |
2,295,272 |
2017-11-16 |
|
| 3 |
Stein Jeffrey |
President & CEO |
275,000 |
2025-04-02 |
|
| 4 |
Daruwala Paul |
Chief Operating Officer |
221,099 |
2022-09-13 |
|
| 5 |
Sandison Taylor |
Chief Medical Officer |
166,836 |
2024-10-02 |
|
| 6 |
Shah Preetam |
Chief Financial Officer |
130,087 |
2024-10-02 |
|
| 7 |
Levine James E. |
Chief Financial Officer |
130,000 |
2021-03-19 |
|
| 8 |
Judice Kevin |
Director |
94,488 |
2015-04-14 |
|
| 9 |
Thye Dirk |
Chief Medical Officer |
80,000 |
2016-03-18 |
|
| 10 |
Onaitis Matthew |
Gnrl Counsel, CFO & Secretary |
72,000 |
2018-04-02 |
|
| 11 |
Forrest Kevin |
Chief Scientific Officer |
60,000 |
2017-04-04 |
|
| 12 |
Karbe Frank |
Chief Financial Officer |
57,500 |
2025-02-26 |
|
| 13 |
Abdollahian Neil |
Chief Business Officer |
55,440 |
2021-04-05 |
|
| 14 |
Bartizal Ken |
Chief Development Officer |
50,000 |
2017-04-04 |
|
| 15 |
Gollaher David L |
Director |
42,500 |
2023-06-23 |
|
| 16 |
Franson Timothy R |
Director |
42,500 |
2023-06-23 |
|
| 17 |
Ward Shane |
COO & CLO |
39,674 |
2025-04-02 |
|
| 18 |
Davarpanah Nicole Negar |
Chief Medical Officer |
20,000 |
2025-05-12 |
|
| 19 |
Johnson Brady |
Vice President, Finance |
20,000 |
2022-04-04 |
|
| 20 |
Tari Leslie |
Chief Scientific Officer |
16,215 |
2025-03-13 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2025-06-18 |
Merson James |
Director |
RSU Award |
11,100 |
$21.31 |
$236.54K |
| 2025-06-18 |
Canale-theakston Carin |
Director |
RSU Award |
11,100 |
$21.31 |
$236.54K |
| 2025-06-18 |
Spencer Ryan |
Director |
RSU Award |
11,100 |
$21.31 |
$236.54K |
| 2025-06-18 |
Resnick Joshua |
Director |
RSU Award |
5,079 |
$21.31 |
$108.23K |
| 2025-06-18 |
Bassler Bonnie L |
Director |
RSU Award |
11,100 |
$21.31 |
$236.54K |
| 2025-06-18 |
Mineo Chrysa |
Director |
RSU Award |
11,100 |
$21.31 |
$236.54K |
| 2025-06-18 |
Schroeder Theodore R |
Director |
RSU Award |
11,100 |
$21.31 |
$236.54K |
| 2025-06-18 |
Ra Capital Management, L.p. |
Director |
RSU Award |
5,079 |
$21.31 |
$108.23K |
| 2025-06-18 |
Burgess Daniel D |
Director |
RSU Award |
11,100 |
$21.31 |
$236.54K |
| 2025-06-03 |
Mineo Chrysa |
Director |
Informative Buy |
1,050 |
$23.44 |
$24.61K |
| 2025-06-02 |
Mineo Chrysa |
Director |
Informative Buy |
2,270 |
$21.71 |
$49.28K |
| 2025-05-01 |
Davarpanah Nicole Negar |
Chief Medical Officer |
RSU Award |
20,000 |
$21.75 |
$435K |
| 2025-05-01 |
Davarpanah Nicole Negar |
Chief Medical Officer |
Unknown |
30,000 |
$21.54 |
$646.2K |
